tiprankstipranks
Trending News
More News >

Beyond Air Implements Reverse Stock Split for Nasdaq Compliance

Story Highlights
  • Beyond Air, Inc. announced a 1-for-20 reverse stock split effective July 14, 2025.
  • The reverse stock split aims to raise the share price above $1.00 to comply with Nasdaq rules.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Beyond Air Implements Reverse Stock Split for Nasdaq Compliance

Don’t Miss TipRanks’ Half-Year Sale

Beyond Air ( (XAIR) ) has shared an announcement.

Beyond Air, Inc. announced a 1-for-20 reverse stock split of its common stock, approved during a special stockholders meeting on June 20, 2025, and effective on July 14, 2025. This move aims to increase the per share bid price above $1.00 to comply with Nasdaq Listing Rule 5550(a)(2). While the reverse stock split will adjust the number of shares held by stockholders, it will not affect the company’s authorized capital stock or the rights of preferred stockholders. The company hopes this action will help regain compliance with Nasdaq requirements, although there is no assurance of achieving the desired effects.

The most recent analyst rating on (XAIR) stock is a Buy with a $1.00 price target. To see the full list of analyst forecasts on Beyond Air stock, see the XAIR Stock Forecast page.

Spark’s Take on XAIR Stock

According to Spark, TipRanks’ AI Analyst, XAIR is a Neutral.

The overall stock score reflects substantial financial risks due to persistent losses and negative cash flows, which are partially mitigated by positive revenue growth and strategic corporate actions. Despite technical and valuation challenges, the company’s strategic initiatives and international expansion offer some potential for future improvement.

To see Spark’s full report on XAIR stock, click here.

More about Beyond Air

Beyond Air, Inc. is a company operating in the medical technology industry, focusing on developing innovative solutions for respiratory conditions. The company’s primary product offerings include advanced medical devices aimed at improving respiratory health, with a market focus on enhancing treatment options for patients with lung diseases.

Average Trading Volume: 3,353,635

Technical Sentiment Signal: Strong Sell

Current Market Cap: $19.3M

For detailed information about XAIR stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1